These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29415625)

  • 1. A predominant cardiac phenotype of Anderson-Fabry disease in presence of a MYBPC3 gene mutation and a LAMA4 gene mutation.
    Laenens D; Koopman P; Cools T
    Acta Cardiol; 2019 Feb; 74(1):84-85. PubMed ID: 29415625
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe apical hypertrophic cardiomyopathy with Ser 236 Gly mutation in MYBPC3: A three-year follow-up investigation.
    Cen X; Zheng J; Hu X; Qu B
    Hellenic J Cardiol; 2017; 58(5):366-368. PubMed ID: 28062247
    [No Abstract]   [Full Text] [Related]  

  • 3. A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy.
    Vitale G; Pasquale F; Leone O; Cenacchi G; Niro F; Torrado M; Maneiro E; Graziosi M; Ditaranto R; Capelli I; Monserrat L; Rapezzi C; Biagini E
    Can J Cardiol; 2020 Sep; 36(9):1554.e1-1554.e3. PubMed ID: 32710830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabry Disease and/or Hypertrophic Cardiomyopathy.
    Anan R
    Int Heart J; 2017 May; 58(3):305-306. PubMed ID: 28539575
    [No Abstract]   [Full Text] [Related]  

  • 5. First Reported Case of Fabry Disease Caused by a Somatic Mosaicism in the GLA Gene.
    Barriales-Villa R; Ochoa JP; Santomé-Collazo JL; Mosquera-Reboredo J; Cao-Vilariño M; Monserrat L
    Rev Esp Cardiol (Engl Ed); 2019 Jul; 72(7):585-587. PubMed ID: 30029973
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fabry disease among hypertrophic cardiomyopathy of genetic origin].
    Bouvagnet P; Millat G; Rousson R; Gilbert G; Derumeaux G
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S233-7. PubMed ID: 21211671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Many Faces of Fabry's Cardiomyopathy.
    Jain R; Kalvin L; Johnson B; Muthukumar L; Khandheria BK; Tajik AJ
    JACC Cardiovasc Imaging; 2018 Apr; 11(4):644-647. PubMed ID: 29361493
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening Mutations of MYBPC3 in 114 Unrelated Patients with Hypertrophic Cardiomyopathy by Targeted Capture and Next-generation Sequencing.
    Liu X; Jiang T; Piao C; Li X; Guo J; Zheng S; Zhang X; Cai T; Du J
    Sci Rep; 2015 Jun; 5():11411. PubMed ID: 26090888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy.
    Marsiglia JD; Credidio FL; de Oliveira TG; Reis RF; Antunes Mde O; de Araujo AQ; Pedrosa RP; Barbosa-Ferreira JM; Mady C; Krieger JE; Arteaga-Fernandez E; Pereira Ada C
    Am Heart J; 2013 Oct; 166(4):775-82. PubMed ID: 24093860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabry disease in patients with hypertrophic cardiomyopathy: a practical approach to diagnosis.
    Seo J; Kim M; Hong GR; Kim DS; Son JW; Cho IJ; Shim CY; Chang HJ; Ha JW; Chung N
    J Hum Genet; 2016 Sep; 61(9):775-80. PubMed ID: 27225851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of dilated cardiomyopathy-like hypertrophic cardiomyopathy caused by a 13261 G > A mutation in cardiac myosin-binding protein C gene].
    Wang SX; Zou YB; Fu CY; Wang H; Wang JZ; Song XD; Chen JZ; Hui RT
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jan; 35(1):17-20. PubMed ID: 17386157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy.
    Richard P; Isnard R; Carrier L; Dubourg O; Donatien Y; Mathieu B; Bonne G; Gary F; Charron P; Hagege M; Komajda M; Schwartz K; Hainque B
    J Med Genet; 1999 Jul; 36(7):542-5. PubMed ID: 10424815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late-onset primary LVH HCM versus cardiac fabry variant.
    Frustaci A; Pieroni M; Chimenti C
    J Am Coll Cardiol; 2002 Apr; 39(8):1405-6; author reply 1406. PubMed ID: 11955864
    [No Abstract]   [Full Text] [Related]  

  • 14. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy.
    Erdmann J; Raible J; Maki-Abadi J; Hummel M; Hammann J; Wollnik B; Frantz E; Fleck E; Hetzer R; Regitz-Zagrosek V
    J Am Coll Cardiol; 2001 Aug; 38(2):322-30. PubMed ID: 11499719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry disease with resting outflow obstruction masquerading as hypertrophic cardiomyopathy.
    Geske JB; Jouni H; Aubry MC; Gersh BJ
    J Am Coll Cardiol; 2014 May; 63(17):e43. PubMed ID: 24632283
    [No Abstract]   [Full Text] [Related]  

  • 16. A Novel Founder Mutation in MYBPC3: Phenotypic Comparison With the Most Prevalent MYBPC3 Mutation in Spain.
    Sabater-Molina M; Saura D; García-Molina Sáez E; González-Carrillo J; Polo L; Pérez-Sánchez I; Olmo MDC; Oliva-Sandoval MJ; Barriales-Villa R; Carbonell P; Pascual-Figal D; Gimeno JR
    Rev Esp Cardiol (Engl Ed); 2017 Feb; 70(2):105-114. PubMed ID: 28029522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative Diagnosis of Anderson-Fabry Disease in Patients With Obstructive Hypertrophic Cardiomyopathy Undergoing Surgical Myectomy.
    Cecchi F; Iascone M; Maurizi N; Pezzoli L; Binaco I; Biagini E; Fibbi ML; Olivotto I; Pieruzzi F; Fruntelata A; Dorobantu L; Rapezzi C; Ferrazzi P
    JAMA Cardiol; 2017 Oct; 2(10):1147-1151. PubMed ID: 28793143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic variations in carriers of predicted protein-truncating genetic variants in MYBPC3: an autopsy-based case series.
    Williams N; Marion R; McDonald TV; Wang D; Zhou B; Eng LS; Um SY; Lin Y; Ruiter K; Rojas L; Sampson BA; Tang Y
    Cardiovasc Pathol; 2018; 37():30-33. PubMed ID: 30282064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy.
    Jørgenrud B; Jalanko M; Heliö T; Jääskeläinen P; Laine M; Hilvo M; Nieminen MS; Laakso M; Hyötyläinen T; Orešič M; Kuusisto J
    PLoS One; 2015; 10(8):e0134184. PubMed ID: 26267065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of Fabry disease: usefulness of the clinical investigation].
    Demontis R
    Rev Med Interne; 2010 Dec; 31 Suppl 2():S229-32. PubMed ID: 21211670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.